Гидроксихлорохин не в состоянии помочь пациентам с коронавирусом в самом большом исследовании препарата на сегодняшний день thumbnail

Гидроксихлорохин не в состоянии помочь пациентам с коронавирусом в самом большом исследовании препарата на сегодняшний день

Translating…

In aseek printed in the Fresh EnglandJournal of Treatment, scientists led by a team at Columbia College chanced on that folk contaminated with COVID-19 takinghydroxychloroquinestop no longer fare better than these no longer receiving the drug.

The seek printed Thursday is the finest to this point to study the drug, which is accepted by the U.S. Food and Drug Administration to take care of malaria and obvious autoimmune concerns, as a remedy forCOVID-19. Dr. Neil Schluger, chief of the division of pulmonary, hypersensitive reaction and vital care remedy at Columbia, and his team studied extra than 1,300 sufferers admitted to Fresh York-Presbyterian Effectively being facility-Columbia College Irving Medical Center for COVID-19. Some received hydroxychloroquine on an off-tag foundation, a apply that lets in doctors to prescribe a drug that has been accepted for one illness to take care of any other — on this case, COVID-19. About 60% of the sufferers received hydroxychloroquine for roughly 5 days. They didn’t repeat any decrease charge of desiring ventilators or a decrease possibility of dying throughout the seek length when when in contrast with of us no longer getting the drug.

“We don’t deem at this level, given the totality of evidence, that it is cheap to routinely give this drug to sufferers,” says Schluger. “We don’t inquire of the rationale for doing that.” Whereas the seek didn’t randomly place of us to receive the drug or placebo and evaluate their outcomes, the substantial replacement of sufferers eager suggests the findings are stable.

In step with the consequences, Schluger says doctors at his sanatorium maintain already modified their advice in regards to the use of hydroxychloroquine to take care of COVID-19. “Our guidance early on had urged giving hydroxychloroquine to hospitalized sufferers, and we up to this point that guidance to take away that recommendation,” he says.

The usual pork up of hydroxychloroquine came largely from a tiny seek conducted in France that urged of us receiving the drug did better than these no longer getting it. Within the U.S., President Trump moreover expressed curiosity in the drug as a that you just would possibly possibly possibly possibly deem of technique to manipulate the increasing pandemic. Alternatively,Dr. Anthony Fauci, director of the National Institute of Hypersensitivity and Infectious Illnesses and member of Trump’s White House Coronavirus Project Drive, urged warning and suggested extra rigorous studies and files on the drug’s halt on COVID-19.

Silent, Schluger says the pressing wish to support sufferers in the heart of a plague led many doctors and hospitals to latch on to hydroxychloroquine as a potentially effective remedy. “Physicians inquire of sufferers who’re dying at an wonderful charge, and wish to prevent something to study out to support them,” he says. “Nonetheless I deem the history of remedy reveals us that some hunches are lawful and loads, many, many of them are unsuitable.” In awitnessconducted by health care polling firm Sermo, 55% of physicians all the method in which during the field who maintain been surveyed reported the use of hydroxychloroquine. Totally 29%, on the other hand, rated it as extremely stable — the drug is linked to higher possibility of irregular heart rhythms.

The outcomes of basically the most contemporary seek tend to interchange how doctors take care of hospitalized sufferers who’re severely in bad health. Nonetheless Schluger says it’s peaceful that you just would possibly possibly possibly possibly deem of that hydroxychloroquine can play a role in controlling COVID-19, possibly as a mode to prevent infection amongst of us who’re at high possibility of getting uncovered to the virus, comparable to health care workers. Other studies are investigating that possibility.

“It’s basically vital for us to know which treatments work, and which prevent no longer, so sufferers maintain to be equipped the likelihood to be in a scientific trial,” says Schluger. “It’s likely the only thing they’ll stop for themselves and for society as an entire, so we can accept answers basically mercurial to call the treatments that work and discard the treatments that don’t work.”

The Coronavirus Transient.Every thing it is most life like to know in regards to the world unfold of COVID-19

Thank you!

For your security, we now maintain sent a confirmation email to the take care of you entered. Click the hyperlink to verify your subscription and birth receiving our newsletters. If you manufacture no longer accept the confirmation within 10 minutes, please verify your narrate mail folder.

Contact usateditors@time.com.

Leave a Comment